Warby Parker WRBY
Warby Parker FY 2021: revenue $540.8M; diluted EPS −$2.21
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001504776-22-000007
- Document
- 10-K
- Exhibit 4.3
- Warrants or notes
- Exhibit 10.8
- Material contract
Key figures from this report
These are the numbers Warby Parker reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Revenue$540.8MNo year-earlier figure tagged10-K income statement, on EDGAR
- Net income−$144.3MNo year-earlier figure tagged10-K income statement, on EDGAR
- Diluted EPS−$2.21No year-earlier figure tagged10-K income statement, on EDGAR
- Cash and cash equivalents$256.4MNo year-earlier figure tagged10-K balance sheet, on EDGAR
- Cash from operations−$32.0MNo year-earlier figure tagged10-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 3851 and related industry codes: the same peer list as the financial tables.
- National Vision Holdings EYE public float $1.3B, Jun 28, 2025
- Staar Surgical STAA public float $884M, Jun 27, 2025
- Bausch & Lomb BLCO public float $557M, Jun 30, 2025
- RxSight RXST public float $504M, Jun 30, 2025